Themis Medicare Faces Financial Strain Amid Declining Performance Metrics and Cash Reserves

Themis Medicare has recently undergone a financial trend adjustment, reflecting significant challenges in its performance metrics for the quarter ending March 2025. The company's financial score has notably declined, indicating a tough period marked by various underperforming indicators.
Key metrics reveal a concerning picture for Themis Medicare. The profit after tax (PAT) for the quarter stands at Rs -9.66 crore, representing a substantial decline compared to the previous four-quarter average. Additionally, the return on capital employed (ROCE) is at a low of 10.24%, and the operating profit to interest ratio is also troubling, recorded at -2.36 times. The company's cash and cash equivalents have dwindled to Rs 12.84 crore, while net sales have fallen to Rs 71.70 crore. Other indicators, such as PBDIT and earnings per share, are at their lowest levels, further emphasizing the financial strain.

Despite these challenges, Themis Medicare has shown resilience in its stock performance relative to the Sensex over various time frames. In the past week, the stock returned 3.25%, contrasting with a -1.91% return from the Sensex. Over the past three years, Themis Medicare has outperformed the Sensex with a return of 60.40% compared to 49.01%. However, the year-to-date performance shows a stark decline of 46.23%, highlighting the need for strategic adjustments moving forward.